Lecanemab May Reverse Alzheimer's Disease But 3 Deaths Raise Questions

The U.S. Food and Drug Administration (FDA) granted Leqembi accelerated approval on Jan. 6, 2023. It is the seventh ...

Related Keywords

Japan ,Japanese ,Stephanie Zhang ,University Of Mississippi Medical Center ,Drug Administration ,Granted Anti Amyloid Drug ,Improve Cognitive ,Including Three ,New England Journal ,Memory Impairment ,Neurodegenerative Dementia ,Mississippi Medical ,Alzheimer 039s Disease ,Death ,Fda ,Lecanemab ,Leqembi ,Side Effect ,The Epoch Times ,